Chordate Medical is one of the companies participating at this years’ Life Science Day in Gothenburg on March 8th. Chordate CEO Anders Weilandt will present the company and how K.O.S can become a global and valuable treatment option for people with chronic migraines.
The Life Science day takes place at the Wallenberg conference center next to Sahlgrenska in Gothenburg and consists of presentations by 15 companies active in the Life Science and Medtech sector, as well as professors and researchers.
The event is live streamed and can be seen afterwards at https://www.lifesciencedagen.se/
For more information, please contact:
Anders Weilandt, CEO
anders.weilandt@chordate.com
Cell: +46 733-874277
About Chordate
Chordate Medical Holding AB (publ) is a medical technology company that has developed, patented and CE-marked a neuromodulation and drug-free treatment technology for chronic migraine and chronic nasal congestion (rhinitis), Kinetic Oscillation Stimulation (K.O.S). The K.O.S-treatment has clinically proven efficacy according to scientific studies. The company's products are available via distributors to clinics in the Nordic countries, Germany, the UK, Italy, Israel, and Saudi Arabia. Chordate Medical is listed on Nasdaq First North Growth Market Stockholm (ticker: CMH). Read more at www.chordate.com
The company's Certified Adviser on Nasdaq First North Growth Market Stockholm is Västra Hamnen Corporate Finance AB.
N.B. The English text is an in-house translation of the original Swedish text. Should there be any disparities between the Swedish and the English text, the Swedish text shall prevail.